AZN - Biden administration secures 230K more RSV injections for infants
2023-12-14 15:46:45 ET
More on AstraZeneca, Sanofi, etc.
- AstraZeneca: A $1.1B Shot In The Arm From Icosavax Acquisition
- AstraZeneca Is Feeling The Weight Of The Market In 2023
- R&D Day
- AbbVie, AstraZeneca targeted for improper use of drug patents
- Icosavax deal CVR based on FDA approval for IVX-A12, sales in EU, UK, Canada
For further details see:
Biden administration secures 230K more RSV injections for infants